Clinical Trial Update: Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating autologous dendritic cells loaded with autologous tumor associated antigens for newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Autologous dendritic cells loaded with autologous tumor associated antigens

Snippet

Sponsor: Aivita Biomedical, Inc. | Conditions: Newly Diagnosed Glioblastoma | Phase 2 | Status: UNKNOWN